Diversifying selective pressure on influenza B virus hemagglutinin

Journal of Medical Virology

Volumn 81, Issue 1, 2009, Pages 114-124

  Shen, Jun ^a   Kirk, Brian D ^a   Ma, Jianpeng ^a,b   Wang, Qinghua ^b  

^a Rice University   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Antibody selection; Antigenic drift; Molecular evolution; Positive selection

Indexed keywords

AMINO ACID; EPITOPE; INFLUENZA VIRUS HEMAGGLUTININ; HEMAGGLUTININ HA1, INFLUENZA B VIRUS; UNCLASSIFIED DRUG; VIRUS RNA;

AMINO ACID SUBSTITUTION; ANTIBODY DETECTION; ARTICLE; GENE SEQUENCE; INFLUENZA VIRUS B; NONHUMAN; PHYLOGENY; PROTEIN ANALYSIS; PROTEIN STRUCTURE; VIRUS ISOLATION; VIRUS STRAIN; CHEMICAL STRUCTURE; DNA SEQUENCE; GENETIC SELECTION; GENETICS; IMMUNOLOGY; MOLECULAR EVOLUTION; PROTEIN TERTIARY STRUCTURE;

INFLUENZA B VIRUS;

EPITOPES; EVOLUTION, MOLECULAR; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA B VIRUS; MODELS, MOLECULAR; PHYLOGENY; PROTEIN STRUCTURE, TERTIARY; RNA, VIRAL; SELECTION (GENETICS); SEQUENCE ANALYSIS, DNA;

EID: 58149260926     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21335     Document Type: Article

References (61)

1. Abed Y, Coulthart MB, Li Y, Boivin G. 2003. Evolution of surface and nonstructural-1 genes of influenza B viruses isolated in the Province of Quebec, Canada, during the 1998-2001 period. Virus Genes 27:125-135.
2. Air GM, Gibbs AJ, Laver WG, Webster RG. 1990. Evolutionary changes in influenza B are not primarily governed by antibody selection. Proc Natl Acad Sci USA 87:3884-3888.
3. Anisimova M, Bielawski JP, Yang Z. 2002. Accuracy and power of bayes prediction of amino acid sites under positive selection. Mol Biol Evol 19:950-958.
4. Barbey-Martin C, Gigant B, Bizebard T, Calder LJ, Wharton SA, Skehel JJ, Knossow M. 2002. An antibody that prevents the hemagglutinin low pH fusogenic transition. Virology 294:70-74.
5. Berton MT, Webster RG. 1985. The antigenic structure of the influenza B virus hemagglutinin: Operational and topological mapping with monoclonal antibodies. Virology 143:583-594.
6. Berton MT, Naeve CW, Webster RG. 1984. Antigenic structure of the influenza B virus hemagglutinin: Nucleotide sequence analysis of antigenic variants selected with monoclonal antibodies. J Virol 52:919-927.
7. Bizebard T, Gigant B, Rigolet P, Rasmussen B, Diat O, Bosecke P, Wharton SA, Skehel JJ, Knossow M. 1995. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody. Nature 376:92-94.
8. Bizebard T, Barbey-Martin C, Fleury D, Gigant B, Barrere B, Skehel JJ, Knossow M. 2001. Structural studies on viral escape from antibody neutralization. Curr Top Microbiol Immunol 260:55-64.
9. Bootman JS, Robertson JS. 1988. Sequence analysis of the hemagglutinin of B/Ann Arbor/1/86, an epidemiologically significant variant of influenza B virus. Virology 166:271-274.
10. Bush RM, Fitch WM, Bender CA, Cox NJ. 1999. Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol 16:1457-1465.
11. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. 1982. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31:417-427.
12. Chen R, Holmes EC. 2008. The evolutionary dynamics of human influenza B virus. J Mol Evol.
13. Chen JM, Guo YJ, Wu KY, Guo JF, Wang M, Dong J, Zhang Y, Li Z, Shu YL. 2007. Exploration of the emergence of the Victoria lineage of influenza B virus. Arch Virol 152:415-422.
14. Daniels RS, Douglas AR, Skehel JJ, Wiley DC. 1983. Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion. J Gen Virol 64:1657-1662.
15. Deely JJ, Lindley DV. 1981. Bayes empirical bayes. J Am Stat Assoc 76:833-841.
16. Fleury D, Barrere B, Bizebard T, Daniels RS, Skehel JJ, Knossow M. 1999. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nat Struct Biol 6:530-534.
17. Gambaryan AS, Robertson JS, Matrosovich MN. 1999. Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses. Virology 258:232-239.
18. Gigant B, Barbey-Martin C, Bizebard T, Fleury D, Daniels R, Skehel JJ, Knossow M. 2000. A neutralizing antibody Fab-influenza haemagglutinin complex with an unprecedented 2:1 stoichiometry: Characterization and crystallization. Acta Crystallogr D Biol Crystallogr 56:1067-1069.
19. Hovanec DL, Air GM. 1984. Antigenic structure of the hemagglutinin of influenza virus B/Hong Kong/8/73 as determined from gene sequence analysis of variants selected with monoclonal antibodies. Virology 139:384-392.
20. Ikonen N, Pyhala R, Axelin T, Kleemola M, Korpela H. 2005. Reappearance of influenza B/Victoria/2/87-lineage viruses: Epidemic activity, genetic diversity and vaccination efficacy in the Finnish Defence Forces. Epidemiol Infect 133:263-271.
21. Kanegae Y, Sugita S, Endo A, Ishida M, Senya S, Osako K, Nerome K, Oya A. 1990. Evolutionary pattern of the hemagglutinin gene of influenza B viruses isolated in Japan: Cocirculating lineages in the same epidemic season. J Virol 64:2860-2865.
22. Knossow M, Gaudier M, Douglas A, Barrere B, Bizebard T, Barbey C, Gigant B, Skehel JJ. 2002. Mechanism of neutralization of influenza virus infectivity by antibodies. Virology 302:294-298.
23. Krystal M, Elliott RM, Benz EW Jr, Young JF, Palese P. 1982. Evolution of influenza A and B viruses: Conservation of structural features in the hemagglutinin genes. Proc Natl Acad Sci USA 79:4800-4804.
24. Krystal M, Young JF, Palese P, Wilson IA, Skehel JJ, Wiley DC. 1983. Sequential mutations in hemagglutinins of influenza B virus isolates: Definition of antigenic domains. Proc Natl Acad Sci USA 80:4527-4531.
25. Lubeck MD, Schulman JL, Palese P. 1980. Antigenic variants of influenza viruses: Marked differences in the frequencies of variants selected with different monoclonal antibodies. Virology 102:458-462.
26. Lugovtsev VY, Vodeiko GM, Levandowski RA. 2005. Mutational pattern of influenza B viruses adapted to high growth replication in embryonated eggs. Virus Res 109:149-157.
27. Lugovtsev VY, Vodeiko GM, Strupczewski CM, Ye Z, Levandowski RA. 2007. Generation of the influenza B viruses with improved growth phenotype by substitution of specific amino acids of hemagglutinin. Virology 365:315-323.
28. Macken C, Lu H, Goodman J, Boykin L. 2001. The value of a database in surveillance and vaccine selection. In: Osterhaus A, Cox N, Hampson AW, editors. Options for the control of the influenza IV. Amsterdam: Elsevier Sciences. pp. 103-106.
29. Matsuzaki Y, Sugawara K, Takashita E, Muraki Y, Hongo S, Katsushima N, Mizuta K, Nishimura H. 2004. Genetic diversity of influenza B virus: The frequent reassortment and cocirculation of the genetically distinct reassortant viruses in a community. J Med Virol 74:132-140.
30. McCullers JA, Wang GC, He S, Webster RG. 1999. Reassortment and insertion-deletion are strategies for the evolution of influenza B viruses in nature. J Virol 73:7343-7348.
31. McCullers JA, Saito T, Iverson AR. 2004. Multiple genotypes of influenza B virus circulated between 1979 and 2003. J Virol 78:12817-12828.
32. Muyanga J, Matsuzaki Y, Sugawara K, Kimura K, Mizuta K, Ndumba I, Muraki Y, Tsuchiya E, Hongo S, Kasolo FC, Numazaki Y, Nakamura K. 2001. Antigenic and genetic analyses of influenza B viruses isolated in Lusaka, Zambia in 1999. Arch Virol 146:1667-1679.
33. Nakagawa N, Kubota R, Maeda A, Nakagawa T, Okuno Y. 2000. Heterogeneity of influenza B virus strains in one epidemic season differentiated by monoclonal antibodies and nucleotide sequences. J Clin Microbiol 38:3467-3469.
34. Nakagawa N, Kubota R, Morikawa S, Nakagawa T, Baba K, Okuno Y. 2001a. Characterization of new epidemic strains of influenza B virus by using neutralizing monoclonal antibodies. J Med Virol 65:745-750.
35. Nakagawa N, Kubota R, Nakagawa T, Okuno Y. 2001b. Antigenic variants with amino acid deletions clarify a neutralizing epitope specific for influenza B virus Victoria group strains. J Gen Virol 82:2169-2172.
36. Nakagawa N, Kubota R, Nakagawa T, Okuno Y. 2003. Neutralizing epitopes specific for influenza B virus Yamagata group strains are in the 'loop'. J Gen Virol 84:769-773.
37. Nakagawa N, Kubota R, Maeda A, Okuno Y. 2004. Influenza B virus victoria group with a new glycosylation site was epidemic in Japan in the 2002-2003 season. J Clin Microbiol 42:3295-3297.
38. Nakagawa N, Kubota R, Okuno Y. 2005. Variation of the conserved neutralizing epitope in influenza B virus victoria group isolates in Japan. J Clin Microbiol 43:4212-4214.
39. Nakagawa N, Suzuoki J, Kubota R, Kobatake S, Okuno Y. 2006. Discovery of the neutralizing epitope common to influenza B virus victoria group isolates in Japan. J Clin Microbiol 44:1564-1566.
40. Nerome R, Hiromoto Y, Sugita S, Tanabe N, Ishida M, Matsumoto M, Lindstrom SE, Takahashi T, Nerome K. 1998. Evolutionary characteristics of influenza B virus since its first isolation in 1940: Dynamic circulation of deletion and insertion mechanism. Arch Virol 143:1569-1583.
41. Oxford JS, Schild GC, Corcoran T, Newman R, Major D, Robertson J, Bootman J, Higgins P, al-Nakib W, Tyrrell DA. 1990. A host-cell-selected variant of influenza B virus with a single nucleotide substitution in HA affecting a potential glycosylation site was attenuated in virulence for volunteers. Arch Virol 110:37-46.
42. Oxford JS, Newman R, Corcoran T, Bootman J, Major D, Yates P, Robertson J, Schild GC. 1991. Direct isolation in eggs of influenza A (H1N1) and B viruses with haemagglutinins of different antigenic and amino acid composition. J Gen Virol 72:185-189.
43. Pechirra P, Nunes B, Coelho A, Ribeiro C, Goncalves P, Pedro S, Castro LC, Rebelo-de-Andrade H. 2005. Molecular characterization of the HA gene of influenza type B viruses. J Med Virol 77:541-549.
44. Robertson JS, Naeve CW, Webster RG, Bootman JS, Newman R, Schild GC. 1985. Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology 143:166-174.
45. Robertson JS, Bootman JS, Nicolson C, Major D, Robertson EW, Wood JM. 1990. The hemagglutinin of influenza B virus present in clinical material is a single species identical to that of mammalian cell-grown virus. Virology 179:35-40.
46. Rota PA, Wallis TR, Harmon MW, Rota JS, Kendal AP, Nerome K. 1990. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 175:59-68.
47. Rota PA, Hemphill ML, Whistler T, Regnery HL, Kendal AP. 1992. Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus. J Gen Virol 73:2737-2742.
48. Saito T, Nakaya Y, Suzuki T, Ito R, Saito H, Takao S, Sahara K, Odagiri T, Murata T, Usui T, Suzuki Y, Tashiro M. 2004. Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation. J Med Virol 74:336-343.
49. Schild GC, Oxford JS, de Jong JC, Webster RG. 1983. Evidence for host-cell selection of influenza virus antigenic variants. Nature 303:706-709.
50. Schulze IT. 1997. Effects of glycosylation on the properties and functions of influenza virus hemagglutinin. J Infect Dis 176:S24-S28.
51. Shaw MW, Xu X, Li Y, Normand S, Ueki RT, Kunimoto GY, Hall H, Klimov A, Cox NJ, Subbarao K. 2002. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology 303:1-8.
52. Skehel JJ, Wiley DC. 2000. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu Rev Biochem 69:531-569.
53. Skehel JJ, Stevens DJ, Daniels RS, Douglas AR, Knossow M, Wilson IA, Wiley DC. 1984. A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci USA 81:1779-1783.
54. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680.
55. Verhoeyen M, Van Rompuy L, Jou WM, Huylebroeck D, Fiers W. 1983. Complete nucleotide sequence of the influenza B/Singapore/222/79 virus hemagglutinin gene and comparison with the B/Lee/40 hemagglutinin. Nucleic Acids Res 11:4703-4712.
56. Wang Q, Cheng F, Lu M, Tian X, Ma J. 2008. Crystal structure of unliganded influenza B virus hemagglutinin. J Virol 82:3011-3020.
57. Webster RG, Berton MT. 1981. Analysis of antigenic drift in the haemagglutinin molecule of influenza B virus with monoclonal antibodies. J Gen Virol 54:243-251.
58. Yang Z. 1997. PAML: A program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci 13:555-556.
59. Yang Z. 2007. PAML 4:Phylogenetic analysis by maximum likelihood. Mol Biol Evol 24:1586-1591.
60. Yang Z, Nielsen R, Goldman N, Pedersen AM. 2000. Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 155:431-449.
61. Yang Z, Wong WS, Nielsen R. 2005. Bayes empirical bayes inference of amino acid sites under positive selection. Mol Biol Evol 22:1107-1118.